| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Replimune Group, Inc. | Chief Financial Officer | Common Stock | 194,368 | $1,774,579 | $9.13 | 19 Dec 2025 | Direct |
| PTC THERAPEUTICS, INC. | CHIEF FINANCIAL OFFICER | Stock Option (Right to Buy) | 42,500 | $1,149,625 | $27.05 | 05 Jan 2023 | Direct |
| PTC THERAPEUTICS, INC. | CHIEF FINANCIAL OFFICER | Common Stock | 38,925 | $1,065,782 | $27.38 | 27 Mar 2023 | Direct |
| Replimune Group, Inc. | Chief Financial Officer | Employee Stock Option (right to buy) | 67,500 | 01 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| REPL | Replimune Group, Inc. | 19 Dec 2025 | 1 | $0 | 4 | Chief Financial Officer | 19 Dec 2025, 17:12 |
| REPL | Replimune Group, Inc. | 15 Aug 2025 | 1 | -$49,157 | 4 | Chief Financial Officer | 19 Aug 2025, 20:30 |
| REPL | Replimune Group, Inc. | 20 May 2025 | 1 | -$20,407 | 4 | Chief Financial Officer | 22 May 2025, 21:44 |
| REPL | Replimune Group, Inc. | 01 Apr 2025 | 2 | $0 | 4 | Chief Financial Officer | 03 Apr 2025, 20:02 |
| REPL | Replimune Group, Inc. | 16 Aug 2024 | 1 | -$90,989 | 4 | Chief Financial Officer | 19 Aug 2024, 20:00 |
| REPL | Replimune Group, Inc. | 01 Apr 2024 | 2 | $0 | 4 | Chief Financial Officer | 03 Apr 2024, 20:01 |
| REPL | Replimune Group, Inc. | 18 Sep 2023 | 2 | $0 | 4 | Chief Financial Officer | 20 Sep 2023, 21:04 |
| REPL | Replimune Group, Inc. | 18 Sep 2023 | 0 | $0 | 3 | Chief Financial Officer | 20 Sep 2023, 21:03 |
| PTCT | PTC THERAPEUTICS, INC. | 27 Mar 2023 | 1 | -$331,335 | 4 | CHIEF FINANCIAL OFFICER | 29 Mar 2023, 16:19 |
| PTCT | PTC THERAPEUTICS, INC. | 31 Jan 2023 | 1 | -$26,236 | 4 | CHIEF FINANCIAL OFFICER | 02 Feb 2023, 15:20 |
| PTCT | PTC THERAPEUTICS, INC. | 24 Jan 2023 | 1 | -$10,582 | 4 | CHIEF FINANCIAL OFFICER | 26 Jan 2023, 15:21 |
| PTCT | PTC THERAPEUTICS, INC. | 10 Jan 2023 | 2 | -$39,880 | 4 | CHIEF FINANCIAL OFFICER | 12 Jan 2023, 15:37 |
| PTCT | PTC THERAPEUTICS, INC. | 09 Jan 2023 | 1 | -$31,575 | 4 | CHIEF FINANCIAL OFFICER | 11 Jan 2023, 17:15 |
| PTCT | PTC THERAPEUTICS, INC. | 05 Jan 2023 | 2 | $0 | 4 | CHIEF FINANCIAL OFFICER | 09 Jan 2023, 15:55 |
| PTCT | PTC THERAPEUTICS, INC. | 31 Mar 2022 | 1 | -$298,824 | 4 | CHIEF FINANCIAL OFFICER | 01 Apr 2022, 16:20 |
| PTCT | PTC THERAPEUTICS, INC. | 01 Feb 2022 | 1 | -$22,121 | 4 | Chief Financial Officer | 03 Feb 2022, 15:58 |
| PTCT | PTC THERAPEUTICS, INC. | 25 Jan 2022 | 1 | -$8,295 | 4 | Chief Financial Officer | 27 Jan 2022, 15:01 |
| PTCT | PTC THERAPEUTICS, INC. | 07 Jan 2022 | 3 | -$30,820 | 4 | Chief Financial Officer | 11 Jan 2022, 15:18 |
| PTCT | PTC THERAPEUTICS, INC. | 04 Jan 2022 | 1 | -$7,121 | 4 | Chief Financial Officer | 06 Jan 2022, 15:10 |